What one share of Co-Diagnostics holds
Co-Diagnostics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.30 |
|---|---|
| Profit | −$19.44 |
| Capex (buildings and equipment) | $0.15 |
| Free cash flow | −$11.35 |
| Cash and investments | $0.75 |
| Book value | $2.61 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$5.85 | $0.04 | −$4.02 | — | −$9.09 |
| 2017 | — | −$19.05 | $0.35 | −$9.14 | — | $9.38 |
| 2018 | — | −$15.07 | $0.10 | −$9.90 | — | −$2.46 |
| 2019 | — | −$11.09 | $0.20 | −$10.09 | — | $3.01 |
| 2020 | $79.88 | $45.51 | $0.83 | $29.35 | — | $70.06 |
| 2021 | $98.20 | $36.78 | $0.67 | $40.54 | — | $119.29 |
| 2022 | $32.61 | −$13.57 | $1.36 | $4.90 | — | $111.28 |
| 2023 | $6.96 | −$36.12 | $1.40 | −$23.97 | — | $82.13 |
| 2024 | $3.87 | −$37.22 | $0.74 | −$29.57 | — | $48.90 |
| 2025 | $0.47 | −$35.25 | $0.53 | −$22.43 | — | $9.85 |
Common questions about Co-Diagnostics
How much does one share of Co-Diagnostics earn?
Over the last 12 months, Co-Diagnostics lost $19.44 for each share on $0.30 of sales.
Does Co-Diagnostics pay a dividend?
Co-Diagnostics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Co-Diagnostics’s book value per share?
Co-Diagnostics’s book value is $2.61 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Co-Diagnostics have?
Each share of Co-Diagnostics has $0.75 of cash and investments, as of June 30, 2026.
What is Co-Diagnostics’s free cash flow per share?
−$11.35 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Co-Diagnostics bought back shares?
Co-Diagnostics’s share count rose about 304% from 2016 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.